Valuation: MRI Interventions Inc

Market Cap 423M 372M 346M 317M 596M 40.78B 606M 4.11B 1.6B 20.05B 1.59B 1.56B 69.32B P/E 2026 *
-12.7x
P/E 2027 * -15x
Enterprise Value 423M 372M 346M 317M 596M 40.78B 606M 4.11B 1.6B 20.05B 1.59B 1.56B 69.32B EV / Sales 2026 *
7.97x
EV / Sales 2027 * 6.61x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 2017-11-06
Director of Finance/CFO 41 2020-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2014-03-09
Chairman 80 2021-02-03
Director/Board Member 49 2017-11-06
Change 5-day change 1-year change 3-year change Capi.($)
-5.04%-33.93% - - 423M
-0.68%+7.57%+16.72%+1.07% 211B
-0.45%-4.70%-5.56%-24.92% 135B
+4.52%-0.08%-28.56%+9.06% 119B
+3.49%+4.36%-56.84%-13.22% 65.77B
-0.49%-2.29%+5.81%+0.46% 47.58B
+1.67%+0.45%-25.82%-33.63% 44.44B
-0.59%+5.88%+15.37%+8.89% 39.14B
-0.54%+4.72%+23.83%+31.27% 36.79B
-0.40%+4.78%+76.10%+2.00% 29.37B
Average +0.16%+0.67%+2.34%-2.11% 80.9B
Weighted average by Cap. +0.81%+0.78%-2.09%-3.89%

Financials

2026 *2027 *
Net sales 53.13M 46.67M 43.4M 39.82M 74.83M 5.12B 75.98M 515M 201M 2.52B 199M 195M 8.7B 64.1M 56.3M 52.36M 48.04M 90.27M 6.17B 91.66M 622M 243M 3.03B 241M 235M 10.49B
Net income -33.07M -29.04M -27.01M -24.78M -46.57M -3.18B -47.29M -321M -125M -1.57B -124M -121M -5.41B -28.63M -25.15M -23.39M -21.46M -40.32M -2.76B -40.95M -278M -109M -1.36B -107M -105M -4.69B
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-